Low level of plasminogen increases risk for mortality in COVID-19 patients

David Della-Morte1,2,3,4, Francesca Pacifici5, Camillo Ricordi6

  • 1Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. david.dellamorte@uniroma2.it.

Cell Death & Disease
|August 6, 2021
PubMed

Insights

Low plasminogen levels are linked to severe COVID-19 complications and mortality. This finding suggests plasminogen may serve as a crucial prognostic biomarker and potential therapeutic target for coronavirus disease 2019.

Area of Science:

  • * Internal Medicine
  • * Pathophysiology
  • * Biochemistry

Background:

  • * Coronavirus disease 2019 (COVID-19) pathophysiology and thromboembolic complications remain incompletely understood.
  • * Thromboembolic events are a major cause of mortality in COVID-19 patients.
  • * Plasminogen, a precursor to fibrinolysis, has been hypothesized to play a role in COVID-19 complications.

Purpose of the Study:

  • * To investigate the association between plasminogen levels and COVID-19-related outcomes.
  • * To explore plasminogen's potential as a prognostic biomarker and therapeutic target in COVID-19.

Main Methods:

  • * Analysis of plasminogen levels in 55 Caucasian COVID-19 patients.
  • * Correlation of plasminogen levels with inflammatory markers (CRP, PCT, IL-6), coagulation markers (D-dimer, INR, APTT), and organ dysfunction markers.
  • * Multidimensional analysis to assess the relationship between coagulation, inflammation, and plasminogen.

Main Results:

  • * Low plasminogen levels significantly correlated with heightened inflammation, coagulation activation, and organ dysfunction.
  • * Plasminogen clustering with IL-6 suggests a shared activation pathway in disease complications.
  • * Low plasminogen levels strongly predicted mortality in COVID-19 patients, even after adjusting for confounders.

Conclusions:

  • * Plasminogen plays a critical role in managing the complex mechanisms underlying COVID-19 complications.
  • * Plasminogen levels can serve as a valuable prognostic biomarker for COVID-19 patients.
  • * Targeting plasminogen may offer a therapeutic strategy against severe COVID-19.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.5K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
76
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
66
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.8K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K